查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611566

心律调节器市场规模、份额和趋势分析报告：2025-2030 年按产品、应用、最终用途、地区和细分市场进行的预测

Pacemaker Market Size, Share & Trends Analysis Report By Product (External, Implantable), By Application (Arrhythmias, Congestive Heart Failure), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 165 Pages | 商品交期: 2-10个工作天内

价格

心律调节器市场成长和趋势

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球心律调节器市场规模预计将达到 77 亿美元。

预计2025年至2030年该市场将以5.7%的复合年增长率成长。由于医疗技术的进步和全球对心律管理解决方案的需求不断增加，该市场正在经历稳定成长。无导线心律调节器、设备小型化和延长电池寿命等技术创新大大提高了心律调节器植入的有效性和便利性。整合远端监控功能还允许医疗保健提供者远端追踪心律调节器功能和患者健康状况，从而减少医院就诊次数，从而改善患者护理。 2024年11月，欧洲首例单室无线心臟心律调节器植入手术在伯恩大学医院进行。这项手术由阿联酋专家主导，证实了该国作为医疗创新领导者的地位及其对培养区域医疗专业人员的承诺。

市场受益于对治疗心搏过缓、心律不整和心臟衰竭等心臟疾病的日益关注。由于心血管疾病仍然是全球死亡的主要原因之一，因此对可靠、有效的起搏装置的需求不断增长。心律调节器越来越被视为改善患者治疗效果的重要解决方案，并在医院和门诊中心广泛采用。由于心律调节器技术的不断进步和心臟治疗需求的不断增加，预计未来几年市场将保持强劲成长。 2023 年 11 月，MedStar 华盛顿医院中心成为美国首批为心率异常缓慢的患者提供 Aveir DR无导线心律调节器系统的机构之一。

心律调节器市场报告亮点

  • 植入式心律调节器在产品类型占据主导地位，2024年将占据68.0%的市场占有率，因为它们已被证明可有效治疗心律不整，并广泛应用于临床实践。
  • 2024年，由于心搏过缓过缓的盛行率很高，特别是在老年族群中，心搏过缓领域在应用中占据了27.5%的显着份额。
  • 从最终用途来看，由于医院环境中提供先进的医疗基础设施和专业护理，医院细分市场将在 2024 年占据主导地位。由于越来越多地采用微创手术和更快的恢復时间，门诊病人设施预计将以最快的复合年增长率成长。
  • 由于先进的医疗基础设施、高昂的医疗成本以及较早采用创新心律调节器技术，北美占据了全球市场的最大份额，达到 43.4%。
  • 由于心血管疾病盛行率上升、医疗保健服务的改善以及该地区医疗保健投资的增加，预计亚太地区在预测期内将以最快的复合年增长率增长。
  • 竞争的特点是主要企业实施产品发布、分销协议和战略伙伴关係关係等策略，以显着扩大市场占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章心律调节器市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 心律调节器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章心律调节器市场：按产品分类的估计和趋势分析

  • 全球心律调节器市场：产品仪表板
  • 全球心律调节器市场：产品波动分析
  • 2018-2030年全球心律调节器市场规模、预测及趋势分析
  • 体外心律心律调节器
    • 单室
    • 双腔室
  • 植入式心律调节器
    • 传统的
    • 无引线

第五章心律调节器市场：按应用、估计和趋势分析

  • 全球心律调节器市场：应用仪表板
  • 全球心律调节器市场：应用变化分析
  • 2018-2030年全球心律调节器市场规模、预测及趋势分析
  • 心搏过缓
  • 急性心肌梗塞
  • 心律不整
    • 心房颤动
    • 心臟传导阻滞
    • 长QT症候群
  • 郁血性心臟衰竭
  • 其他的

第六章心律调节器市场：最终用途的估计和趋势分析

  • 全球心律调节器市场：最终用途仪表板
  • 全球心律调节器市场：最终用途变化分析
  • 2018-2030年全球心律调节器市场规模、预测及趋势分析
  • 医院
  • 门诊设施

第七章心律调节器市场：按国家、产品、应用和最终用途进行的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2024年主要企业市场占有率分析
  • 公司简介
    • Osypka Medical GmbH
    • Zoll Medical Corporation
    • Medtronic
    • BIOTRONIK
    • MicroPort Scientific Corporation
    • MEDICO SpA
    • Pacetronix
    • Oscor Inc
    • Boston Scientific Corporation
    • Lepu Medical Technology（Beijing）Co., Ltd.
Product Code: GVR-1-68038-336-2

Pacemaker Market Growth & Trends:

The global pacemaker market size is expected to reach USD 7.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market is experiencing steady growth, driven by advancements in medical technology and an increasing global demand for heart rhythm management solutions. Technological innovations, such as leadless pacemakers, smaller devices, and improved battery life, have significantly enhanced the effectiveness and convenience of pacemaker implantation. Integrating remote monitoring capabilities has also improved patient care by allowing healthcare providers to track pacemaker function and patient health remotely, reducing hospital visits. In November 2024, Europe witnessed its first single-chamber, wireless cardiac pacemaker implantation at Bern University Hospital. This procedure, led by experts from the UAE, underscores the country's position as a leader in medical innovation and its commitment to training regional healthcare professionals.

The market benefits from a greater focus on treating heart conditions such as bradycardia, arrhythmias, and heart failure. As cardiovascular diseases remain one of the leading causes of death globally, the need for reliable and effective pacing devices continues to rise. Pacemakers are increasingly seen as a critical solution for improving patient outcomes, leading to their widespread adoption in hospitals and outpatient centers. With continuous advancements in pacemaker technology and a growing demand for cardiac care, the market is expected to maintain strong growth in the coming years. In November 2023, MedStar Washington Hospital Center became one of the first institutions in the U.S. to offer the Aveir DR Leadless Pacemaker System for patients with abnormally slow heart rates.

Pacemaker Market Report Highlights:

  • The implantable pacemaker segment dominated the product category in 2024 with 68.0% of the market share due to its proven effectiveness in treating heart rhythm disorders and widespread adoption in clinical practice.
  • In 2024, the bradycardia segment accounted for a substantial share of 27.5% by application owing to the high prevalence of bradycardia, particularly among aging populations.
  • In terms of end use, the hospital segment dominated in 2024 due to the advanced healthcare infrastructure and specialized care available in hospital settings. Outpatient facilities are anticipated to grow at the fastest CAGR owing to the increasing adoption of minimally invasive procedures and shorter recovery times.
  • North America held the largest share of 43.4% of the global market due to advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative pacemaker technologies.
  • Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to rising cardiovascular disease prevalence, improving healthcare access, and increasing healthcare investments in the region.
  • The competition features key players implementing strategies like product launches, distribution agreements, and strategic partnerships, which have greatly expanded their market share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Pacemaker Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
      • 3.2.1.2. Favorable reimbursement policies
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulation and approvals
      • 3.2.2.2. Product Recalls
  • 3.3. Pacemaker Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Pacemaker Market: Product Estimates & Trend Analysis

  • 4.1. Global Pacemaker Market: Product Dashboard
  • 4.2. Global Pacemaker Market: Product Movement Analysis
  • 4.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 4.4. External Pacemakers
    • 4.4.1. External pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Single Chamber
      • 4.4.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Dual Chamber
      • 4.4.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Implantable Pacemakers
    • 4.5.1. Implantable pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Conventional
      • 4.5.2.1. Conventional market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.2.2. Single Chamber
        • 4.5.2.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.2.3. Dual Chamber
        • 4.5.2.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.2.4. Biventricular Chamber
        • 4.5.2.4.1. Biventricular Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Leadless
      • 4.5.3.1. Leadless market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.3.2. Single Chamber
        • 4.5.3.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.3.3. Dual Chamber
        • 4.5.3.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Pacemaker Market: Application Estimates & Trend Analysis

  • 5.1. Global Pacemaker Market: Application Dashboard
  • 5.2. Global Pacemaker Market: Application Movement Analysis
  • 5.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 5.4. Bradycardia
    • 5.4.1. Bradycardia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Acute Myocardial Infarction
    • 5.5.1. Acute myocardial infarction market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Arrhythmias
    • 5.6.1. Arrhythmias market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.2. Atrial Fibrillation
      • 5.6.2.1. Atrial Fibrillation market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.3. Heart Block
      • 5.6.3.1. Heart Block market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.4. Long QT Syndrome
      • 5.6.4.1. Long QT syndrome market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Congestive Heart Failure
    • 5.7.1. Congestive heart failure market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Pacemaker Market: End Use Estimates & Trend Analysis

  • 6.1. Global Pacemaker Market: End Use Dashboard
  • 6.2. Global Pacemaker Market: End Use Movement Analysis
  • 6.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Outpatient Facilities
    • 6.5.1. Outpatient Facilities market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country, Product, Application, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Osypka Medical GmbH
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Zoll Medical Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Medtronic
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BIOTRONIK
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. MicroPort Scientific Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. MEDICO SpA
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Pacetronix
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Oscor Inc
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Boston Scientific Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Lepu Medical Technology (Beijing) Co., Ltd.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global Pacemaker Market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 52 China Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 53 China Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Pacemaker Market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Pacemaker Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Pacemaker Market: Product Outlook Key Takeaways
  • Fig. 15 Global Pacemaker Market: Product Movement Analysis
  • Fig. 16 Global External Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global External Pacemakers Single Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global External Pacemakers Dual Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Implantable Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Implantable Pacemaker Conventional Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Implantable Pacemaker Conventional Single Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Implantable Pacemaker Conventional Dual Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Implantable Pacemaker Conventional Biventricular Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Implantable Pacemaker Leadless Market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Implantable Pacemaker Leadless Single Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Implantable Pacemaker Leadless Dual Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Pacemaker Market: Application Outlook Key Takeaways
  • Fig. 28 Global Pacemaker Market: Application Movement Analysis
  • Fig. 29 Global Bradycardia Market, 2018 - 2030 (USD Million)
  • Fig. 30 Global Acute Myocardial Infarction Market, 2018 - 2030 (USD Million)
  • Fig. 31 Global Arrhythmias Market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 33 Global Heart Block Market, 2018 - 2030 (USD Million)
  • Fig. 34 Global Long QT Syndrome Market, 2018 - 2030 (USD Million)
  • Fig. 35 Global Congestive Heart Failure Market, 2018 - 2030 (USD Million)
  • Fig. 36 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Pacemaker Market: End Use Outlook Key Takeaways
  • Fig. 38 Global Pacemaker Market: End Use Movement Analysis
  • Fig. 39 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 40 Global Outpatient Facilities Market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 Global Pacemaker Market: Region Movement Analysis
  • Fig. 44 North America Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 46 Canada Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 50 UK Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 51 France Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia pacific Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 61 India Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 73 Strategy framework